COMPANY

Onconaut Therapeutics

Keywords: oncology cancer small molecule colorectal cancer

Location: Aurora, CO · source · Nov 4, 2024

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $760K (STTR Phase II 4R42CA306378-02, extension, notice Aug 31, 2026). NIH RePORTER 4R42CA306378-02 (Aug 31, 2026)
Evidence (1 event)
- Aug 31, 2026 · NIH RePORTER 4R42CA306378-02
  Organization: ONCONAUT THERAPEUTICS INC.; City/State: AURORA, CO; Project number: 4R42CA306378-02; Activity code: R42; Fiscal year: 2026; Award notice date: 2026-08-31; FY total cost (award amount): 760110; Administering IC: National Cancer Institute; Project title: CHD1Li Targeted Combinations with Chemotherapy to Address Unmet Needs in Colorectal Cancer Treatment; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals